Click on image to view larger version.

Fig. 1. Gross morphology of mutant ventral prostates. Ventral prostate showing the
opaque appearance of control ducts (A) and the transparent appearance of
Hoxb13 homozygous mutant ducts (B) (yellow arrows). (C) X-gal
staining of 5-week-old Hoxb13lacZ heterozygote
reproductive organs show preferential expression of Hoxb13 within the ventral
prostate; Hoxb13 continues to be strongly expressed in the ventral
prostate of 1-year-old animals. (D-F) There is a dose-dependent X-gal staining
intensity between wild-type (D), Hoxb13 heterozygote (E) and
Hoxb13 homozygous mutant (F) ventral prostates (white arrowheads).
Homozygous mutant prostates frequently exhibit swelling in individual ducts
(E; red arrowhead). (G-I) Reductions in ventral prostate duct tips are
observed in Hoxb13/Hoxd13 double homozygous mutants. Dark-field
micrographs of ventral prostate microdissections of wild type (G),
Hoxb13 homozygous mutants (H) and Hoxb13/Hoxd13 double
homozygous mutants (I). Significant reductions in number of duct tips and
outgrowth of branches are only seen in double Hoxb13/Hoxd13 mutants
(averages and standard deviations for number of duct tips from 3 prostates for
each genotype are shown below representative photo). (J-L) Postnatal X-gal
staining of developing prostates showing Hoxb13 expression during the time of
extensive ductile morphogenesis. At P10, X-gal staining is barely detectable
(J), but is very strong by P12 in the ventral prostate (K). (L) During
development, all prostatic lobes show strong X-gal staining (P16 shown). B,
bladder; VP,ventral prostate; AP, anterior prostate; dlp, dorsolateral
prostate; SV, seminal vesicle. Scale bars (A-I) 2 mm, (J-L) 1 mm.